Search results
Results From The WOW.Com Content Network
Amlodipine's safety in pregnancy has not been established, although reproductive toxicity at high doses is known. Whether amlodipine enters the milk of breastfeeding mothers is also unknown. [7] [6] Those who have heart failure, or recently had a heart attack, should take amlodipine with caution. [29]
A good time to check your heart rate is in the morning after you’ve had a good night’s sleep, before you get out of bed or grab your morning coffee, says Dr. Steinbaum.
The most efficient way to lower your heart rate is through breathing, says Dr. Wang. “Deep exhalations can decrease your heart rate. Breathing in through the nose for the count of 4, holding it ...
Antiarrhythmic agents, also known as cardiac dysrhythmia medications, are a class of drugs that are used to suppress abnormally fast rhythms (tachycardias), such as atrial fibrillation, supraventricular tachycardia and ventricular tachycardia.
Most people who have taken too much of a calcium channel blocker, especially diltiazem, get slow heart rate and low blood pressure (vasodilatory shock). [1] This can progress to the heart stopping altogether. [2] CCBs of the dihydropyridine group, as well as flunarizine, predominantly cause reflex tachycardia as a reaction to the low blood ...
Because of the heart’s orientation and “suspension” in the chest, sleeping on the left side can cause subtle changes in the heart’s position, says Leonard Ganz, M.D., cardiologist and ...
Slowing down the conduction of electrical activity within the heart, by blocking the calcium channel during the plateau phase of the action potential of the heart (see: cardiac action potential), results in a negative chronotropic effect, or a lowering of heart rate. This can increase the potential for heart block.
Levamlodipine , also known as levoamlodipine or S-amlodipine is a pharmacologically active enantiomer of amlodipine. [1] Amlodipine belongs to the dihydropyridine group of calcium channel blocker used as an antihypertensive and antianginal agent. [2] It was approved by the U.S. FDA in December 2019 and is currently marketed under the brand name ...